<DOC>
	<DOCNO>NCT00801346</DOCNO>
	<brief_summary>RATIONALE : Gathering information metabolic syndrome young patient acute lymphoblastic leukemia may help doctor learn disease . PURPOSE : This phase I trial study metabolic syndrome young patient acute lymphoblastic leukemia remission .</brief_summary>
	<brief_title>Metabolic Syndrome Young Patients With Acute Lymphoblastic Leukemia Remission</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine incidence prevalence component metabolic syndrome ( e.g. , obesity , hypertension , dyslipidemia , insulin resistance ) pediatric patient acute lymphoblastic leukemia remission . - To determine trajectory onset component 1-year period patient undergoing maintenance therapy . Secondary - To identify potential association component metabolic syndrome fatigue , health-related quality life , family history , nutrition , physical activity . - To identify potential biomarkers associate clinical feature metabolic syndrome . - To evaluate whether patient show decrease IGF-1 level . OUTLINE : This two-part study . Patients enrol either part 1 part 2 . - Part 1 : Patients undergo physical exam measurement ( e.g. , body mass index , waist circumference , blood pressure ) baseline ( maintenance course 1 ) 12 month ( maintenance course 5 ) . Patients also undergo blood sample collection baseline 12 month measure laboratory marker ( e.g. , fast lipid profile , fast insulin glucose , IGF-1 , leptin , adiponectin level ) . Patients parent complete family history questionnaire baseline questionnaires assess physical activity , quality life , nutritional intake , fatigue baseline 6 12 month . - Part 2 : Patients parent complete family history questionnaire baseline .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Part 1 Diagnosis precursor Bcell acute lymphoblastic leukemia ( ALL ) In first remission In first 3 month maintenance therapy No Tcell ALL , highrisk ALL , infant ALL ( &lt; 1 year old diagnosis ) Part 2 Diagnosis precursor Bcell Tcell ALL In first remission Must diagnose treat ( least maintenance phase ) Division Pediatric Oncology VanderbiltIngram Cancer Center within past 7 year No highrisk ALL infant ALL ( &lt; 1 year old diagnosis ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior concurrent cranial radiotherapy ( Part 1 )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>fatigue</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
	<keyword>T-cell childhood acute lymphoblastic leukemia</keyword>
</DOC>